MRSA検査の市場規模、シェア、成長分析：製品タイプ別、検査タイプ別、エンドユーザー別、地域別-産業予測、2025～2032年

世界のMRSA検査の市場規模は2023年に45億米ドルと評価され、2024年の46億8,000万米ドルから2032年には64億6,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは4.1％で成長する見通しです。

世界のMRSA検査市場は、抗生物質耐性感染症の迅速な検出に対するヘルスケアシステムの緊急ニーズによって、著しい成長を遂げています。メチシリン耐性黄色ブドウ球菌（MRSA）は、特に病院環境において、依然として公衆衛生上の大きな懸念となっています。MRSA感染の流行が増加するにつれ、正確でタイムリーな診断検査に対する需要も高まっています。さまざまなヘルスケア施設における感染対策への注力は、アウトブレイクを抑制することを目的としたポイントオブケア技術や分子診断技術の採用の増加とともに、市場拡大の主な要因となっています。自動化プラットフォームやPCRベースのアッセイの進歩により検出能力が向上し、臨床転帰が改善されています。さらに、スクリーニングガイドラインの義務化や抗菌薬耐性に対する意識の高まりが、診断企業に費用対効果の高いソリューションの提供を促し、MRSA検査を世界の感染管理戦略にさらに浸透させています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次・一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術分析

MRSA検査市場規模：製品タイプ別、CAGR（2025～2032年）

• 市場概要
• 機器
• 試薬・キット

MRSA検査市場規模：検査タイプ別、CAGR（2025～2032年）

• 市場概要
• 免疫診断検査
• 分子診断検査

MRSA検査市場規模：エンドユーザー別、CAGR（2025～2032年）

• 市場概要
• 病院
• 診断検査室
• 学術研究機関

MRSA検査市場規模：地域別、CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• 3M Co.
• Abbott Laboratories
• ALIFAX Srl
• Arlington Scientific Inc.
• Becton Dickinson and Co.
• bioMerieux SA
• Bio Rad Laboratories Inc.
• Bruker Corp.
• Creative Diagnostics
• Danaher Corp.
• DiaSorin Spa
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• GENSPEED Biotech GmbH
• OpGen Inc.
• Puritan Medical Products Co.
• R Biopharm AG
• Sekisui Diagnostics LLC
• Uniogen Oy
• ZeptoMetrix LLC

結論と提言

Global MRSA Testing Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 4.68 billion in 2024 to USD 6.46 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The global MRSA testing market is witnessing significant growth, driven by healthcare systems' urgent need for rapid detection of antibiotic-resistant infections. Methicillin-resistant Staphylococcus aureus (MRSA) remains a major public health concern, particularly in hospital settings. As the prevalence of MRSA infections rises, so does the demand for accurate and timely diagnostic tests. The focus on infection control in various healthcare facilities is a key factor fueling market expansion, along with the increasing adoption of point-of-care and molecular diagnostic technologies aimed at curbing outbreaks. Advancements in automated platforms and PCR-based assays are enhancing detection capabilities, thus improving clinical outcomes. Additionally, mandatory screening guidelines and heightened awareness of antimicrobial resistance are pushing diagnostic companies to offer cost-effective solutions, further embedding MRSA testing into global infection control strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MRSA Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MRSA Testing Market Segments Analysis

Global MRSA Testing Market is segmented by Product Type, Test Type, End user and region. Based on Product Type, the market is segmented into Instruments and Reagents & Kits. Based on Test Type, the market is segmented into Immunodiagnostic Test and Molecular Diagnostic Test. Based on End user, the market is segmented into Hospitals, Diagnostic Laboratories and Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MRSA Testing Market

The increasing prevalence of antibiotic-resistant bacteria, particularly MRSA and VRSA, is driving a surge in hospital-acquired infections, notably in high-risk environments like intensive care units and dialysis facilities. Contributing factors include prolonged hospitalizations and the use of invasive medical procedures. This alarming trend underscores the urgent necessity for enhanced infection control strategies, as evidenced by concerning rates of MRSA colonization documented by health organizations such as the CDC and NHS. Consequently, the global MRSA testing market is expanding to address these critical healthcare challenges and improve patient outcomes through more effective diagnostic and treatment options.

Restraints in the Global MRSA Testing Market

The Global MRSA Testing market faces challenges primarily related to patient safety, particularly for vulnerable populations that rely heavily on healthcare services. The transmission of MRSA primarily occurs through direct contact and the use of medical devices. Additionally, contamination issues extend beyond traditional healthcare settings, impacting industries such as telecommunications and electronics, especially during the surface mount technology (SMT) and printed circuit board (PCB) assembly processes. This highlights a pressing need for effective infection prevention measures across various sectors, emphasizing that MRSA concerns are not limited to healthcare environments alone. Addressing these challenges is crucial for overall safety and risk management.

Market Trends of the Global MRSA Testing Market

The Global MRSA Testing market is experiencing a significant trend towards the adoption of AI-powered diagnostic platforms, transforming traditional testing methodologies. These innovative tools enhance diagnostic workflows by automating result interpretation, expediting image analysis, and improving detection accuracy, ultimately fostering better patient outcomes. With the implementation of AI, laboratories can achieve quicker turnaround times and heightened operational efficiency, which is crucial in high-risk healthcare environments. This technological advancement not only streamlines the testing process but also empowers healthcare professionals to implement timely infection control interventions, reflecting a paradigm shift in MRSA management and detection strategies worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global MRSA Testing Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Kits

Global MRSA Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Immunodiagnostic Test
• Molecular Diagnostic Test

Global MRSA Testing Market Size by End user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes

Global MRSA Testing Market Size & CAGR (2025-2032)

• North America (Product Type, Test Type, End user)
  • US
  • Canada
• Europe (Product Type, Test Type, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 3M Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALIFAX Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arlington Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSPEED Biotech GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puritan Medical Products Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R Biopharm AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uniogen Oy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeptoMetrix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations